These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34126894)
1. Formulation, Optimization and Ejeta F; Gabriel T; Joseph NM; Belete A Curr Drug Deliv; 2022; 19(1):129-141. PubMed ID: 34126894 [TBL] [Abstract][Full Text] [Related]
2. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25. Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922 [TBL] [Abstract][Full Text] [Related]
3. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics. Sharma D; Singh G; Kumar D; Singh M J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924 [TBL] [Abstract][Full Text] [Related]
4. Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and Sharma D; Singh R; Singh G Turk J Pharm Sci; 2018 Apr; 15(1):29-37. PubMed ID: 32454637 [TBL] [Abstract][Full Text] [Related]
5. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants. Goel H; Tiwary AK; Rana V Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940 [TBL] [Abstract][Full Text] [Related]
6. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. Sharma D ISRN Pharm; 2013; 2013():674507. PubMed ID: 23956881 [TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet. Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670 [TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of orodispersible tablets of diazepam. Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267 [TBL] [Abstract][Full Text] [Related]
9. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression. Tafere C; Yilma Z; Abrha S; Yehualaw A PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014 [TBL] [Abstract][Full Text] [Related]
10. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum. Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214 [TBL] [Abstract][Full Text] [Related]
11. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet. Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230 [TBL] [Abstract][Full Text] [Related]
12. Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization. M Tawfeek H; Hassan YA; Aldawsari MF; H Fayed M Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291402 [TBL] [Abstract][Full Text] [Related]
13. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters. Dhakal B; Thakur JK; Mahato RK; Rawat I; Rabin DC; Chhetri RR; Shah KP; Adhikari A; Pandey J ScientificWorldJournal; 2022; 2022():9618344. PubMed ID: 35645632 [TBL] [Abstract][Full Text] [Related]
14. Formulation development of stronger and quick disintegrating tablets: a crucial effect of chitin. Goel H; Kaur G; Tiwary AK; Rana V Yakugaku Zasshi; 2010 May; 130(5):729-35. PubMed ID: 20460872 [TBL] [Abstract][Full Text] [Related]
15. Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin. Singh J; Philip AK; Pathak K AAPS PharmSciTech; 2008; 9(1):60-6. PubMed ID: 18446462 [TBL] [Abstract][Full Text] [Related]
16. Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method. Kalyankar P; Panzade P; Lahoti S Indian J Pharm Sci; 2015; 77(3):267-73. PubMed ID: 26180271 [TBL] [Abstract][Full Text] [Related]
17. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. Sammour OA; Hammad MA; Megrab NA; Zidan AS AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372 [TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of fast dissolving tablets containing diclofenac sodium using fenugreek gum as a natural superdisintegrant. Kumar MU; Babu MK Asian Pac J Trop Biomed; 2014 May; 4(Suppl 1):S329-34. PubMed ID: 25183106 [TBL] [Abstract][Full Text] [Related]
19. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. Dehghani H; Taheri A; Homayouni A Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108 [TBL] [Abstract][Full Text] [Related]
20. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. Goel H; Vora N; Rana V AAPS PharmSciTech; 2008; 9(3):774-81. PubMed ID: 18584333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]